RUA — Rua Bioscience Share News
0.000.00%
Last trade - 00:00- NZ$11.77m
- NZ$12.99m
- NZ$2.58m
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth
Brief: Rua Bioscience Gets Approval From New Zealand Medicinal Cannabis Agency
Brief: Rua Bioscience Announces Significant UK Market Expansion Through Major Agreement
New Zealand's Rua Bioscience surges most to date on UK distribution deal
Brief: NZ RegCo Approved A Trading Halt Application From Rua Bioscience
Brief: Rua Bioscience Reports Research Partnership To Develop Smoking Cessation Products
Brief: Rua Bioscience Secures Exclusive NZ Distribution Rights For Medical Device
NZ's Rua Bioscience rises on securing exclusive dsitribution for medical device
Brief: Rua Bioscience Secures New Long-Term Supply Arrangement In Germany
NZ's Rua Bioscience falls to over three-month low on discounted capital raising
Brief: Rua Bioscience Says Sales For Q1 FY26 Are A Record
Brief: Rua Bioscience Secured A Total Of NZ$1.2 Mln In New Funding
New Zealand's Rua Bioscience surges on legal resolution with Australia's Cann Group
Brief: Rua Bioscience Says Co & Cann Reach Resolution In Legal Proceedings
Brief: Rua Bioscience Says Up To NZ$2 Million Additional Working Capital
Brief: Rua Bioscience Posts HY Net Loss Before Tax Of NZ$1.8 Million